Antimicrobial Stewardship is a strategic initiative dedicated to the prudent use of antimicrobials, recognizing their critical role in treating bacterial, viral, and fungal infections. By promoting evidence-based practices, Antimicrobial Stewardship Programs (ASPs) aim to optimize patient care outcomes, minimize side effects, and curtail the development of resistance. The multidisciplinary approach involves healthcare professionals in various capacities, including physicians, pharmacists, and infection control specialists. These programs emphasize continuous monitoring, assessment, and feedback to tailor antimicrobial therapy to individual patient needs. Through educational initiatives and adherence to antimicrobial guidelines, Antimicrobial Stewardship contributes to the sustainability of available treatments, ensuring their efficacy for future generations while addressing the evolving landscape of infectious diseases.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : A rare case of meningitis and septicemia due to Streptococcus acidominimus
Percival C Dilla, Region II Trauma and Medical Center, Philippines
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Association between cardiometabolic risk factors and COVID-19 severity in patients of a rural tertiary hospital
Percival C Dilla, Region II Trauma and Medical Center, Philippines